Department of Bone Tumor, Tianjin Hospital, 406 Jiefang Southern Road, Tianjin, China.
Graduate School, Tianjin Medical University, 22 Qixiangtai Road, Tianjin, China.
Cancer Lett. 2020 Apr 10;475:136-142. doi: 10.1016/j.canlet.2020.01.038. Epub 2020 Feb 4.
Bone metastasis is a common complication of cancer, and bone is the third most common metastatic site following the lung and liver. Among the various bones, spine is the most common site of metastatic tumors. The treatment goals of patients with spinal metastases are mostly palliative, with the aim of reducing pain and improving quality of life. The treatment of spinal metastases has made significant progress over the past few decades. Each new technology has tried to solve the shortcomings of its predecessors. Currently, there are no mature algorithms or specific techniques that have proven to be the best for spinal metastases, and the treatment method often relies on operator and institutional preferences or biases in some cases. Percutaneous vertebral augmentation has unique value in the management of spinal metastases, understanding its indications, surgical techniques, uses, advantages and complications is critical to providing optimal patient care. We believe that the application of percutaneous vertebral augmentation alone or combined with other techniques can achieve optimal pain relief and functional improvement in the patients with spinal metastases.
骨转移是癌症的一种常见并发症,骨骼是继肺和肝之后第三大常见转移部位。在各种骨骼中,脊柱是转移瘤最常见的部位。脊柱转移患者的治疗目标主要是姑息性的,旨在减轻疼痛和提高生活质量。在过去几十年中,脊柱转移的治疗取得了重大进展。每种新技术都试图解决其前辈的缺点。目前,还没有成熟的算法或特定技术被证明是治疗脊柱转移的最佳方法,治疗方法通常取决于操作人员和机构的偏好或在某些情况下的偏见。经皮椎体强化在脊柱转移的管理中具有独特的价值,了解其适应证、手术技术、用途、优点和并发症对于提供最佳的患者护理至关重要。我们相信,单独应用或联合其他技术的经皮椎体强化可以实现脊柱转移患者的最佳疼痛缓解和功能改善。